Literature DB >> 19099277

[Pheochromocytoma - still a challenge].

N Reisch1, M K Walz, Z Erlic, H P H Neumann.   

Abstract

Pheochromocytomas are rare, mostly benign catecholamine-producing tumors arising from the chromaffin cells of the adrenal medulla or in the paraganglia. Clinical presentation is highly variable but typically with hypertension, severe headaches, palpitations and sweating. Biochemical testing by 24 h urinary fractioned metanephrines or catecholamines and plasma free metanephrines as the most sensitive screening approach, confirms the catecholamine excess. Computed tomography scan and magnetic resonance imaging of the adrenal glands and abdomen as well as functional imaging with (123)Iod-MIBG scintigraphy and (18)F-dopa positron emission tomography are used for tumor localization. Because approximately a quarter of tumors develop secondary to germ-line mutations, screening for genetic alterations is important. The therapy of choice is the endoscopic adrenal sparing surgery following preoperative alpha-blockade. Regular follow-up remains essential due to possible recurrence and malignancy.

Entities:  

Mesh:

Year:  2009        PMID: 19099277     DOI: 10.1007/s00108-008-2196-7

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  48 in total

1.  Clinical and genetic characteristics of patients with neurofibromatosis type 1 and pheochromocytoma.

Authors:  Birke Bausch; Wiktor Borozdin; Hartmut P H Neumann
Journal:  N Engl J Med       Date:  2006-06-22       Impact factor: 91.245

2.  [(123)I]metaiodobenzylguanidine and [(111)In]octreotide uptake in begnign and malignant pheochromocytomas.

Authors:  E van der Harst; W W de Herder ; H A Bruining; H J Bonjer; R R de Krijger ; S W Lamberts; A H van de Meiracker ; F Boomsma; T Stijnen; E P Krenning; F T Bosman; D J Kwekkeboom
Journal:  J Clin Endocrinol Metab       Date:  2001-02       Impact factor: 5.958

Review 3.  Review: Should patients with apparently sporadic pheochromocytomas or paragangliomas be screened for hereditary syndromes?

Authors:  Camilo Jiménez; Gilbert Cote; Andrew Arnold; Robert F Gagel
Journal:  J Clin Endocrinol Metab       Date:  2006-05-30       Impact factor: 5.958

4.  Pheochromocytoma in Italy: a multicentric retrospective study.

Authors:  M Mannelli; L Ianni; A Cilotti; A Conti
Journal:  Eur J Endocrinol       Date:  1999-12       Impact factor: 6.664

5.  Partial versus total adrenalectomy by the posterior retroperitoneoscopic approach: early and long-term results of 325 consecutive procedures in primary adrenal neoplasias.

Authors:  Martin K Walz; Klaus Peitgen; Daniela Diesing; Stephan Petersenn; Onno E Janssen; Thomas Philipp; Klaus A Metz; Klaus Mann; Kurt W Schmid; Hartmut P H Neumann
Journal:  World J Surg       Date:  2004-11-11       Impact factor: 3.352

6.  Early-onset renal cell carcinoma as a novel extraparaganglial component of SDHB-associated heritable paraganglioma.

Authors:  Sakari Vanharanta; Mary Buchta; Sarah R McWhinney; Sanna K Virta; Mariola Peçzkowska; Carl D Morrison; Rainer Lehtonen; Andrzej Januszewicz; Heikki Järvinen; Matti Juhola; Jukka-Pekka Mecklin; Eero Pukkala; Riitta Herva; Maija Kiuru; Nina N Nupponen; Lauri A Aaltonen; Hartmut P H Neumann; Charis Eng
Journal:  Am J Hum Genet       Date:  2003-12-18       Impact factor: 11.025

7.  Adrenal incidentaloma: review of 197 patients and report of a drug-related false-positive urinary normetanephrine result.

Authors:  Takahiro Ito; Tsuneo Imai; Toyone Kikumori; Arihiro Shibata; Takao Horiba; Hironobu Kobayashi; Masataka Sawaki; Reiko Watanabe; Akimasa Nakao; Tetsuya Kiuchi
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

8.  Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel-Lindau disease.

Authors:  H P Neumann; D P Berger; G Sigmund; U Blum; D Schmidt; R J Parmer; B Volk; G Kirste
Journal:  N Engl J Med       Date:  1993-11-18       Impact factor: 91.245

9.  Adrenal incidentaloma: clinical characteristics and comparison between patients with and without extraadrenal malignancy.

Authors:  G Tsvetov; I Shimon; C Benbassat
Journal:  J Endocrinol Invest       Date:  2007-09       Impact factor: 4.256

10.  [Screening for phaeochromocytoma : in which hypertensive patients? A semiological study of 2585 patients, including 11 with phaeochromocytoma (author's transl)].

Authors:  P F Plouin; P Degoulet; A Tugayé; M B Ducrocq; J Ménard
Journal:  Nouv Presse Med       Date:  1981-03-07
View more
  1 in total

Review 1.  [Indications for magnetic resonance imaging in Internal Medicine. When do we really need this technology?].

Authors:  A G Schreyer; K Debl; H Herfarth
Journal:  Internist (Berl)       Date:  2010-04       Impact factor: 0.743

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.